Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of eye disorders
Methods of treating eye disorders with (S)-3-amino-4-(difluoromethylenyl)cyclopent- 1-ene-1-carboxylic acid are provided. Methods of treating eye disorders with (1S,3S)-3- amino-4-(difluoromethylidene) cyclopentane- 1 -carboxylic acid or a pharmaceutically acceptable salt thereof are provided. Also provided are therapeutic compositions that may be used to improve one or more symptoms of eye disorders.